Skip to main content
. Author manuscript; available in PMC: 2012 Aug 1.
Published in final edited form as: Mol Genet Metab. 2011 May 6;103(4):307–314. doi: 10.1016/j.ymgme.2011.04.016

Figure 6. Plasma tyrosine concentrations in control and nitisinone-treated alkaptonuria patients over time.

Figure 6

Mean plasma tyrosine levels (μM) measured at each visit over the 36 month study period. The red line is the mean for the nitisinone-treated group. The blue line represents the mean for the control group.